novo nordisk semaglutide nash Wegovy Gets Green Light for Fatty Liver Disease Novo Nordisk leads MASH therapeutic
Description
Common side effects include nausea, diarrhea, dry mouth, dizziness, insomnia, and sexual dysfunction
Starting low and increasing gradually helps manage this
Retatrutide stands out because it affects three hormone receptors at once: GLP-1, GIP, and glucagon
The insurer checks whether the medication is FDA-approved for the diagnosis code on your prescription
